Cochrane Abstracts
Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Prazosin for Raynaud's Phenomenon in Progressive Systemic Sclerosis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437004/all/Prazosin_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis.
Prazosin for Raynaud's phenomenon in progressive systemic sclerosis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/all/Prazosin_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis. Accessed February 5, 2025.
Prazosin for Raynaud's phenomenon in progressive systemic sclerosis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/all/Prazosin_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis
Prazosin for Raynaud's Phenomenon in Progressive Systemic Sclerosis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/all/Prazosin_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Prazosin for Raynaud's phenomenon in progressive systemic sclerosis
ID - 437004
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437004/all/Prazosin_for_Raynaud's_phenomenon_in_progressive_systemic_sclerosis
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
